To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SSBP3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
402 supporting clones for gene SSBP3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL519196 brain, neuroblastoma, neuroblastoma cells .a 1 to 873 1 to 866   tiling clone,   866/870
(99 %)
12 diff
(98.7 %id)
NM_145716.2   .a 72 to 2145 1 to 2074 exact RefSeq,   2074/2074
(100 %)
0 diff
(100 %id)
BC066365 Eye, retinoblastoma .a 239 to 1984 1 to 1746 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1746/1746
(100 %)
0 diff
(100 %id)
TI_1948215504   .a 369 to 1051 130 to 810   fully sequenced,   681/810
(84 %)
6 diff
(99.3 %id)
TI_1948215668   .a 369 to 1051 136 to 818   fully sequenced,   683/818
(83 %)
6 diff
(99.3 %id)
TI_1948215834   .a 369 to 1051 129 to 811   fully sequenced,   683/811
(84 %)
9 diff
(98.9 %id)
TI_1948215985   .a 369 to 1048 127 to 809   fully sequenced,   681/807
(84 %)
12 diff
(98.6 %id)
EL735101 mixed .a 370 to 962 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BI085077 astrocytoma grade IV, cell line, brain .a 448 to 1238 1 to 787       787/787
(100 %)
18 diff
(97.8 %id)
BE256071 eye, retinoblastoma .a 501 to 1040 1 to 540       540/540
(100 %)
0 diff
(100 %id)
BE251609 eye, retinoblastoma .a 502 to 1171 1 to 666       666/757
(87 %)
14 diff
(98.2 %id)
AK001217   .a 635 to 1984 1 to 1350   available from FLJ,   1350/1350
(100 %)
0 diff
(100 %id)
AU123861   .a 636 to 1334 2 to 702   capped   701/702
(99 %)
5 diff
(99.3 %id)
CN365291 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 646 to 1248 187 to 789       603/789
(76 %)
0 diff
(100 %id)
BE797955 lung, small cell carcinoma .a 646 to 1020 249 to 623       375/1016
(36 %)
10 diff
(99.1 %id)
BF769014 epid_tumor .a 649 to 940 295 to 6     Submitted on the opposite strand 290/295
(98 %)
8 diff
(97.3 %id)
BE537406 cervix .a 669 to 1355 1 to 693       693/833
(83 %)
19 diff
(97.8 %id)
DR158430 human embryonic stem cells differentiated toan early endodermal cell type .a 677 to 1467 1 to 791       791/791
(100 %)
5 diff
(99.4 %id)
AA223438 brain, neuroepithelial cells .a 752 to 1020 1 to 270       270/294
(91 %)
5 diff
(98.3 %id)
BE791748 lung, small cell carcinoma .a 780 to 1566 1 to 787       787/916
(85 %)
17 diff
(98.2 %id)
BE257977 eye, retinoblastoma .a 800 to 1404 1 to 611       609/650
(93 %)
12 diff
(98.2 %id)
CN365284 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 807 to 1426 6 to 626       621/626
(99 %)
1 diff
(99.9 %id)
TI_1948215505   .a 990 to 1536 669 to 124   fully sequenced,   546/669
(81 %)
0 diff
(100 %id)
TI_1948215669   .a 990 to 1536 668 to 123   fully sequenced,   546/668
(81 %)
0 diff
(100 %id)
TI_1948215835   .a 990 to 1536 670 to 125   fully sequenced,   546/670
(81 %)
0 diff
(100 %id)
TI_1948215986   .a 990 to 1536 671 to 126   fully sequenced,   546/671
(81 %)
0 diff
(100 %id)
AA223160 brain, neuroepithelial cells .a 1591 to 2008 426 to 1   tiling clone,   426/426
(100 %)
9 diff
(97.9 %id)
NM_018070.3   .b 1 to 2014 1 to 2014 exact RefSeq,   2014/2014
(100 %)
0 diff
(100 %id)
AF500116   .b 84 to 1609 1 to 1526 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1526/1526
(100 %)
0 diff
(100 %id)
BC003605 Placenta, choriocarcinoma .b 273 to 1609 1 to 1337 exact available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1337/1337
(100 %)
0 diff
(100 %id)
EL733226 mixed .b 299 to 813 1 to 515       515/516
(99 %)
3 diff
(99.5 %id)
NM_001009955.2   .c 1 to 2106 1 to 2106 exact RefSeq,   2106/2106
(100 %)
0 diff
(100 %id)
DN602300 human embryonic stem cells .c 28 to 789 4 to 765   tiling clone,   762/779
(97 %)
7 diff
(99.2 %id)
CX866389 embryonic stem .c 37 to 720 1 to 684   tiling clone, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 684/684
(100 %)
0 diff
(100 %id)
CR977262 T-Lymphocytes .c 39 to 300 1 to 262       262/262
(100 %)
3 diff
(98.9 %id)
BX376679 Neuroblastoma Cot 50-normalized .c 42 to 988 1 to 938       938/1008
(93 %)
27 diff
(97.4 %id)
BX374893 Neuroblastoma Cot 25-normalized .c 43 to 687 1 to 637       637/995
(64 %)
17 diff
(98.3 %id)
BX380585 Placenta Cot 25-normalized .c 43 to 994 1 to 945   fully sequenced,   945/945
(100 %)
18 diff
(98.1 %id)
AL515452 neuroblastoma, placenta .c 45 to 687 1 to 645       645/1081
(59 %)
28 diff
(97.5 %id)
CN270942 embryonic stem cells, DMSO-treated H9 cellline .c 231 to 429 1 to 196       196/196
(100 %)
2 diff
(99.0 %id)
CR735578 blood, natural killer cells, cell line .c 251 to 777 29 to 555       527/555
(94 %)
6 diff
(99.0 %id)
BG709295 brain, hypothalamus .c 261 to 687 1 to 436       436/694
(62 %)
9 diff
(98.8 %id)
DB496643.
matches multiple genes
hypothalamus .c 266 to 745 1 to 486     also hits gene MRPL37 486/486
(100 %)
5 diff
(99.0 %id)
BU183971 eye, retinoblastoma .c 283 to 687 1 to 405       405/956
(42 %)
0 diff
(100 %id)
CA392169 eye, RPE/choroid .c 300 to 731 1 to 438       438/438
(100 %)
2 diff
(99.6 %id)
BQ878654 dorsal root ganglia .c 324 to 1227 1 to 909       909/910
(99 %)
15 diff
(98.4 %id)
BC127865 PCR rescued clones, C list .c 330 to 710 385 to 5     Submitted on the opposite strand 381/392
(97 %)
0 diff
(100 %id)
BC127866 PCR rescued clones, C list .c 330 to 710 9 to 395       387/399
(96 %)
6 diff
(98.5 %id)
BM562730 astrocytoma grade IV, cell line, brain .c 335 to 1132 1 to 799       799/984
(81 %)
2 diff
(99.8 %id)
BM558610 amelanotic melanoma, cell line, skin .c 352 to 1129 1 to 780       780/1110
(70 %)
4 diff
(99.7 %id)
AK289474 cerebellum .c 403 to 1989 1 to 1587 exact tiling clone,   1587/1587
(100 %)
0 diff
(100 %id)
DA065537 cerebellum .c 404 to 986 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
AW905511 nervous_normal .c 423 to 613 1 to 191       191/201
(95 %)
9 diff
(95.6 %id)
CN418235 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 427 to 1140 1 to 714       714/714
(100 %)
3 diff
(99.6 %id)
BU154185 eye, retinoblastoma .c 433 to 1257 20 to 850       831/886
(93 %)
15 diff
(98.4 %id)
AW851072 colon .c 443 to 1030 1 to 589       589/589
(100 %)
5 diff
(99.2 %id)
AW851139 colon .c 443 to 945 1 to 503       503/503
(100 %)
0 diff
(100 %id)
AW851206 colon .c 443 to 904 1 to 462       462/462
(100 %)
0 diff
(100 %id)
AW851343 colon .c 443 to 904 1 to 462       462/462
(100 %)
0 diff
(100 %id)
BX448457 fetal liver, Liver .c 468 to 1212 1 to 737       737/737
(100 %)
11 diff
(98.6 %id)
DA568606 whole embryo, mainly head .c 481 to 1350 2 to 869   capped   868/868
(100 %)
9 diff
(99.0 %id)
DN993741 brain, whole brain .c 483 to 1118 1 to 636       636/636
(100 %)
4 diff
(99.4 %id)
BM712044 eye, lens .c 550 to 1113 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
DT216851 brain .c 602 to 1190 25 to 613       589/613
(96 %)
6 diff
(99.1 %id)
TI_151754360   .c 613 to 1250 682 to 42       641/995
(64 %)
3 diff
(99.7 %id)
BM696396 eye, lens .c 633 to 1322 1 to 690       690/690
(100 %)
0 diff
(100 %id)
BM352425 Pancreas, Purified pancreatic islet .c 649 to 1141 1 to 493       493/493
(100 %)
0 diff
(100 %id)
CK822387 Pancreas, Purified pancreatic islet .c 658 to 1185 1 to 528     Submitted on the opposite strand 528/528
(100 %)
6 diff
(98.9 %id)
CR982902 T-Lymphocytes .c 682 to 1467 1 to 788       788/794
(99 %)
4 diff
(99.5 %id)
BF343724 brain, glioblastoma with EGFR amplification .c 736 to 1522 1 to 781       781/830
(94 %)
21 diff
(97.5 %id)
BE395133 endometrium, adenocarcinoma cell line, uterus .c 760 to 1411 1 to 652       652/655
(99 %)
6 diff
(99.1 %id)
CN365285 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 787 to 1335 1 to 549       549/549
(100 %)
4 diff
(99.3 %id)
BM810142 amelanotic melanoma, cell line, skin .c 793 to 1578 19 to 803       785/1181
(66 %)
11 diff
(99.1 %id)
BG992544 head_neck .c 816 to 1093 1 to 278       278/278
(100 %)
6 diff
(97.9 %id)
BC004335 Uterus, endometrium adenocarcinoma .c 847 to 1945 1 to 1099   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1099/1099
(100 %)
0 diff
(100 %id)
CV026370 mixed .c 883 to 1439 1 to 557       557/557
(100 %)
12 diff
(97.9 %id)
TI_1948145140   .c 883 to 1352 125 to 594       470/497
(94 %)
6 diff
(98.8 %id)
TI_1948145397   .c 883 to 1382 126 to 625       500/527
(94 %)
6 diff
(98.9 %id)
TI_1948145639   .c 883 to 1356 129 to 602       474/501
(94 %)
6 diff
(98.9 %id)
BE733625 choriocarcinoma, placenta .c 895 to 1607 1 to 718       718/718
(100 %)
13 diff
(98.2 %id)
H40776 brain .c 903 to 1175 1 to 274       274/277
(98 %)
6 diff
(97.9 %id)
CB215418 normal endometrium, late proliferativephase, cycle day 13, uterus .c 923 to 1519 1 to 597       597/597
(100 %)
0 diff
(100 %id)
CN365286 embryonic stem cells, DMSO-treated H9 cellline .c 942 to 1276 1 to 335       335/335
(100 %)
0 diff
(100 %id)
CN365292 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 942 to 1509 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
BE542200 cervix .c 949 to 1633 1 to 681       681/727
(93 %)
14 diff
(98.1 %id)
AA311609   .c 950 to 1406 1 to 457       457/457
(100 %)
2 diff
(99.6 %id)
BF171255 blood .c 963 to 1073 1 to 113       113/116
(97 %)
7 diff
(94.0 %id)
CB147484 Liver .c 964 to 1511 1 to 548       548/548
(100 %)
0 diff
(100 %id)
BE407607 choriocarcinoma, placenta .c 967 to 1608 1 to 644       644/755
(85 %)
5 diff
(99.4 %id)
TI_57240200   .c 973 to 1624 20 to 671       657/695
(94 %)
7 diff
(99.0 %id)
AA380759   .c 976 to 1241 1 to 269       269/271
(99 %)
4 diff
(98.6 %id)
BX430362 neuroblastoma .c 976 to 1221 1 to 249       252/249
(101 %)
13 diff
(94.8 %id)
BX430271 placenta .c 979 to 1327 1 to 348       348/359
(96 %)
11 diff
(97.0 %id)
BX380584 Placenta Cot 25-normalized .c 979 to 1912 935 to 1   fully sequenced,   935/935
(100 %)
3 diff
(99.7 %id)
BM014203 breast, mammary adenocarcinoma, cell line .c 979 to 1632 7 to 660       656/663
(98 %)
13 diff
(98.1 %id)
TI_59392188   .c 979 to 1632 106 to 759       656/663
(98 %)
13 diff
(98.1 %id)
TI_1948145141   .c 979 to 1497 650 to 131       520/1373
(37 %)
8 diff
(99.5 %id)
BI916705 brain .c 980 to 1624 1 to 645       645/669
(96 %)
1 diff
(99.9 %id)
TI_1948144937   .c 982 to 1497 647 to 130       518/1355
(38 %)
18 diff
(98.7 %id)
BG256260 adenocarcinoma, cell line, Prostate .c 995 to 1617 1 to 628       628/1230
(51 %)
15 diff
(98.8 %id)
TI_1948145640   .c 1044 to 1497 585 to 133       453/1369
(33 %)
3 diff
(99.8 %id)
BG749394 eye, normal pigmented retinal epithelium .c 1068 to 1579 1 to 513       513/968
(52 %)
2 diff
(99.8 %id)
AA354442   .c 1085 to 1399 11 to 326       316/326
(96 %)
13 diff
(96.1 %id)
AA354654   .c 1085 to 1324 11 to 250       240/250
(96 %)
6 diff
(97.6 %id)
BX370848 Neuroblastoma Cot 25-normalized .c 1088 to 1831 825 to 75       751/860
(87 %)
14 diff
(98.4 %id)
BM766084 stomach .c 1106 to 1505 1 to 400       400/400
(100 %)
0 diff
(100 %id)
BG674498 skin .c 1110 to 1614 1 to 504       504/779
(64 %)
2 diff
(99.8 %id)
BU540944 epithelioid carcinoma cell line, Pancreas .c 1120 to 1942 1 to 824   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 824/828
(99 %)
2 diff
(99.8 %id)
BU620580 cell lines, Chondrosarcoma .c 1141 to 1717 577 to 1       577/577
(100 %)
4 diff
(99.4 %id)
CN365290 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1159 to 1792 1 to 636       636/636
(100 %)
3 diff
(99.6 %id)
BF811969 colon_ins .c 1181 to 1639 20 to 479       460/494
(93 %)
11 diff
(97.8 %id)
BF812261 colon_ins .c 1188 to 1639 6 to 456       451/457
(98 %)
12 diff
(97.4 %id)
BF803463 colon_ins .c 1190 to 1639 1 to 448       448/449
(99 %)
9 diff
(98.0 %id)
BF811972 colon_ins .c 1190 to 1639 1 to 448       448/453
(98 %)
12 diff
(97.4 %id)
BF812262 colon_ins .c 1190 to 1631 1 to 441       441/450
(98 %)
4 diff
(99.2 %id)
BQ323981 colon_ins .c 1191 to 1617 1 to 426       426/435
(97 %)
10 diff
(97.8 %id)
AA082411 heart .c 1198 to 1392 10 to 203       194/203
(95 %)
13 diff
(93.6 %id)
BF381158 uterus_tumor .c 1199 to 1619 12 to 431       420/455
(92 %)
10 diff
(97.9 %id)
CR607705 Placenta Cot 25-normalized .c 1250 to 2111 1 to 862   tiling clone,   862/862
(100 %)
0 diff
(100 %id)
BX386510 Placenta Cot 25-normalized .c 1250 to 2111 1 to 860       860/860
(100 %)
15 diff
(98.3 %id)
DB504756.
matches multiple genes
hypothalamus .c 1252 to 1668 1 to 420     also hits gene MRPL37 422/437
(96 %)
19 diff
(95.7 %id)
BX386509 Placenta Cot 25-normalized .c 1259 to 2061 816 to 14       803/825
(97 %)
2 diff
(99.8 %id)
BX340413 Placenta Cot 25-normalized .c 1263 to 2111 1 to 851       851/851
(100 %)
17 diff
(98.1 %id)
BI091645 cervix .c 1299 to 1640 1 to 343       343/677
(50 %)
6 diff
(99.2 %id)
N79881 multiple sclerosis lesions .c 1302 to 1745 1 to 444       444/444
(100 %)
4 diff
(99.1 %id)
AF086085   .c 1306 to 1945 1 to 640   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 640/640
(100 %)
0 diff
(100 %id)
AA363972 pineal body .c 1315 to 1613 1 to 302       302/302
(100 %)
3 diff
(99.1 %id)
AA099075 colon, tumor .c 1316 to 1740 1 to 440   fully sequenced,   440/440
(100 %)
14 diff
(96.9 %id)
AA128471 uterus .c 1346 to 1783 1 to 441       441/441
(100 %)
6 diff
(98.7 %id)
AA130264 uterus .c 1346 to 1807 1 to 464       464/464
(100 %)
4 diff
(99.2 %id)
CK005563 brain/CNS, Human Brain - Frontal Cortex .c 1348 to 1989 1 to 635       635/687
(92 %)
17 diff
(97.6 %id)
BU602811 mixed (pool of 40 RNAs) .c 1350 to 1945 1 to 597       597/637
(93 %)
14 diff
(97.9 %id)
AA326916 colon .c 1364 to 1777 1 to 411       411/411
(100 %)
9 diff
(97.9 %id)
AA775212 lung .c 1364 to 1701 382 to 45   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 338/338
(100 %)
1 diff
(99.8 %id)
CN365287 embryonic stem cells, DMSO-treated H9 cellline .c 1381 to 1633 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BM668455.
matches multiple genes
eye, human retina .c 1385 to 1963 579 to 1     also hits gene LOC100129321 579/579
(100 %)
2 diff
(99.7 %id)
AA732801 heart .c 1390 to 1945 555 to 1       555/555
(100 %)
7 diff
(98.8 %id)
BG896192 cartilage .c 1424 to 1945 38 to 559   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 522/559
(93 %)
6 diff
(99.0 %id)
CN365289 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1429 to 1823 1 to 395       395/395
(100 %)
6 diff
(98.5 %id)
AA737886 pooled germ cell tumors .c 1441 to 1945 505 to 1       505/505
(100 %)
1 diff
(99.9 %id)
AA364062 pineal body .c 1464 to 1790 1 to 327       327/329
(99 %)
3 diff
(99.1 %id)
TI_149300657   .c 1465 to 1945 553 to 70   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 484/960
(50 %)
17 diff
(98.3 %id)
AA046172 uterus .c 1468 to 1724 1 to 256   fully sequenced,   256/256
(100 %)
5 diff
(98.1 %id)
TI_149295012   .c 1470 to 1964 552 to 55       498/1030
(48 %)
0 diff
(100 %id)
TI_154120604   .c 1470 to 1962 572 to 79   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 494/971
(50 %)
6 diff
(99.4 %id)
AA578584 colon, tumor .c 1478 to 1969 492 to 1       492/492
(100 %)
0 diff
(100 %id)
BG420063 Kidney, renal cell adenocarcinoma .c 1498 to 1985 15 to 504       490/1090
(44 %)
6 diff
(99.5 %id)
AA310940   .c 1499 to 1949 1 to 453       453/453
(100 %)
2 diff
(99.6 %id)
AA099596 uterus .c 1509 to 1946 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
BG059676 brain, glioblastoma without EGFR amplification .c 1520 to 1946 427 to 1       427/427
(100 %)
2 diff
(99.6 %id)
AA452210   .c 1539 to 1947 9 to 417       409/417
(98 %)
7 diff
(98.4 %id)
AA928648 pooled germ cell tumors .c 1553 to 1969 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
BM840979 lymph node, stomach .c 1557 to 1951 1 to 395       395/395
(100 %)
2 diff
(99.5 %id)
AA309941   .c 1558 to 1945 1 to 392       392/392
(100 %)
4 diff
(99.0 %id)
BU616898 Cell Line, Chondrosarcoma .c 1584 to 1945 380 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 362/362
(100 %)
6 diff
(98.4 %id)
AA365502 pineal body .c 1607 to 1899 1 to 294       294/294
(100 %)
2 diff
(99.4 %id)
TI_154119172   .c 1610 to 1981 433 to 62       372/1056
(35 %)
0 diff
(100 %id)
CB850857 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1614 to 1945 353 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 335/335
(100 %)
3 diff
(99.2 %id)
BU616770 Cell Line, Chondrosarcoma .c 1614 to 1945 351 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 333/333
(100 %)
1 diff
(99.7 %id)
AA969420 pooled .c 1615 to 1947 333 to 1       333/336
(99 %)
0 diff
(100 %id)
AI738781 colon, colon tumor, RER+ .c 1618 to 1944 328 to 1       328/508
(64 %)
2 diff
(99.7 %id)
BQ017760 Chondrosarcoma, Left Pubic Bone .c 1619 to 1945 345 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 327/327
(100 %)
0 diff
(100 %id)
BX352185 Placenta Cot 25-normalized .c 1620 to 2108 488 to 1       488/492
(99 %)
7 diff
(98.6 %id)
CA426701 cell lines, Chondrosarcoma .c 1620 to 1945 343 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 325/327
(99 %)
2 diff
(99.4 %id)
AI735192 colon .c 1621 to 1945 326 to 3       324/326
(99 %)
0 diff
(100 %id)
AI989658 pooled germ cell tumors .c 1621 to 1945 325 to 1       325/719
(45 %)
1 diff
(99.9 %id)
BE218897 carcinoid, lung .c 1622 to 1948 327 to 1       327/327
(100 %)
0 diff
(100 %id)
BF111190 carcinoid, lung .c 1622 to 1948 327 to 1       327/327
(100 %)
0 diff
(100 %id)
TI_149289138   .c 1622 to 1971 423 to 74       350/423
(82 %)
0 diff
(100 %id)
AI337222 pooled germ cell tumors .c 1623 to 1949 328 to 1       328/460
(71 %)
3 diff
(99.4 %id)
BM970735 lung .c 1623 to 1945 341 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 323/323
(100 %)
1 diff
(99.7 %id)
BF111533 pooled .c 1624 to 1944 321 to 1       321/321
(100 %)
3 diff
(99.1 %id)
BU683522 lung .c 1626 to 1945 338 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 320/320
(100 %)
0 diff
(100 %id)
AI360194 anaplastic oligodendroglioma, brain .c 1627 to 1969 343 to 1       343/343
(100 %)
0 diff
(100 %id)
AI635058 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1627 to 1946 320 to 1       320/320
(100 %)
0 diff
(100 %id)
BU730121 eye, human retina .c 1627 to 1963 337 to 1       337/342
(98 %)
1 diff
(99.8 %id)
BM669137 eye, lens .c 1627 to 1963 337 to 1       337/337
(100 %)
0 diff
(100 %id)
BM352105 Pancreas, Purified pancreatic islet .c 1628 to 1944 317 to 1       317/319
(99 %)
0 diff
(100 %id)
CX866316 embryonic stem .c 1631 to 1945 351 to 37   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 315/315
(100 %)
11 diff
(96.6 %id)
BE468271 carcinoid, lung .c 1632 to 1944 313 to 1       313/313
(100 %)
3 diff
(99.1 %id)
AW083458 colon, moderately differentiated adenocarcinoma .c 1636 to 1951 316 to 1       316/316
(100 %)
1 diff
(99.7 %id)
N62976 multiple sclerosis lesions .c 1637 to 1946 310 to 1       310/310
(100 %)
0 diff
(100 %id)
AI126347 uterus .c 1642 to 1950 309 to 1       309/309
(100 %)
0 diff
(100 %id)
AI148912 placenta .c 1643 to 1970 328 to 1       328/328
(100 %)
0 diff
(100 %id)
AI248755 liver and spleen .c 1643 to 1962 320 to 1       320/320
(100 %)
0 diff
(100 %id)
AI627416 pooled germ cell tumors .c 1643 to 1945 304 to 1       304/304
(100 %)
1 diff
(99.7 %id)
BU622536 cell lines, Chondrosarcoma .c 1643 to 1969 346 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 328/329
(99 %)
2 diff
(99.4 %id)
AA338231 brain .c 1644 to 1942 1 to 305       305/309
(98 %)
14 diff
(95.5 %id)
AI498861 anaplastic oligodendroglioma, brain .c 1644 to 1969 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AI692557 carcinoid, lung .c 1644 to 2107 467 to 3       465/467
(99 %)
0 diff
(100 %id)
CA424215 cell lines, Chondrosarcoma .c 1644 to 1945 321 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 303/304
(99 %)
1 diff
(99.7 %id)
AW952743   .c 1645 to 1945 1 to 301   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 301/301
(100 %)
0 diff
(100 %id)
AI401147 B-cell, chronic lymphotic leukemia .c 1645 to 2108 455 to 1       455/455
(100 %)
4 diff
(99.2 %id)
AI735015 colon .c 1649 to 1941 298 to 6       293/298
(98 %)
0 diff
(100 %id)
AI637756 pooled germ cell tumors .c 1650 to 1945 296 to 1       296/298
(99 %)
0 diff
(100 %id)
AI565975 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1652 to 2106 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AI924364 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1652 to 2107 459 to 4       456/459
(99 %)
0 diff
(100 %id)
BF589012 Kidney .c 1652 to 1962 311 to 1       311/311
(100 %)
7 diff
(97.8 %id)
AI867103 carcinoid, lung .c 1656 to 1948 293 to 1       293/294
(99 %)
0 diff
(100 %id)
AI203041 pooled germ cell tumors .c 1664 to 1948 285 to 1       285/285
(100 %)
0 diff
(100 %id)
AA725886   .c 1666 to 2107 445 to 3       443/445
(99 %)
0 diff
(100 %id)
BU737416.
matches multiple genes
eye, fetal eyes .c 1677 to 2103 444 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base), also hits gene LOC100129321 426/426
(100 %)
4 diff
(99.1 %id)
BG656210 Pancreas, Purified pancreatic islet .c 1678 to 1945 1 to 269   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 269/269
(100 %)
5 diff
(98.2 %id)
AI784268 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1678 to 1945 264 to 1       264/264
(100 %)
5 diff
(98.2 %id)
BM271799 Pancreas, Purified pancreatic islet .c 1679 to 1945 1 to 267   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 267/267
(100 %)
3 diff
(98.9 %id)
Z99397 amygdala, ovary .c 1682 to 1935 1 to 255       255/255
(100 %)
1 diff
(99.7 %id)
AW081027 colon, moderately differentiated adenocarcinoma .c 1696 to 1945 291 to 41   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 251/286
(87 %)
8 diff
(97.3 %id)
AA046046 uterus .c 1697 to 2109 417 to 3   fully sequenced,   415/417
(99 %)
0 diff
(100 %id)
D80651 brain .c 1700 to 1945 1 to 245   fully sequenced,   245/245
(100 %)
3 diff
(98.8 %id)
D61242   .c 1700 to 1945 1 to 246       246/246
(100 %)
0 diff
(100 %id)
AW105260 ovary, tumor, 5 pooled (see description) .c 1706 to 1945 240 to 1       240/240
(100 %)
0 diff
(100 %id)
BX506671 Liver .c 1709 to 2105 1 to 397   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 397/397
(100 %)
1 diff
(99.8 %id)
AA099076 colon, tumor .c 1710 to 2105 398 to 1   fully sequenced,   398/398
(100 %)
2 diff
(99.5 %id)
AA808463 germinal center B cell .c 1712 to 1977 267 to 1       267/267
(100 %)
1 diff
(99.7 %id)
BU735035 eye, lens .c 1720 to 1963 244 to 1       244/244
(100 %)
0 diff
(100 %id)
BX506685 Liver .c 1721 to 2105 1 to 385   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 385/385
(100 %)
2 diff
(99.5 %id)
AW170251 cervix, tumor .c 1723 to 1959 237 to 1       237/237
(100 %)
6 diff
(97.5 %id)
BF108445 carcinoid, lung .c 1723 to 2109 394 to 9       386/395
(97 %)
0 diff
(100 %id)
BU590411 mixed (pool of 40 RNAs) .c 1742 to 1944 1 to 203   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 203/203
(100 %)
2 diff
(99.1 %id)
AW002492 pooled germ cell tumors .c 1743 to 1942 202 to 3       200/202
(99 %)
0 diff
(100 %id)
BM264440 Pancreas, Purified pancreatic islet .c 1744 to 1944 201 to 1       201/201
(100 %)
0 diff
(100 %id)
AI962268 pooled germ cell tumors .c 1744 to 2105 363 to 1       363/363
(100 %)
7 diff
(98.1 %id)
AI368944 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1746 to 2109 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AW589847 pooled germ cell tumors .c 1751 to 1942 194 to 3       192/194
(98 %)
0 diff
(100 %id)
AW082512 esophagus, squamous cell carcinoma .c 1770 to 1945 176 to 1       176/176
(100 %)
0 diff
(100 %id)
AA062808 heart .c 1771 to 1945 176 to 1       176/176
(100 %)
1 diff
(99.5 %id)
AA338230 brain .c 1788 to 1945 158 to 1       158/158
(100 %)
0 diff
(100 %id)
GD157050   .c 1796 to 1963 1 to 164       164/179
(91 %)
13 diff
(92.8 %id)
GD157646   .c 1796 to 1959 1 to 163       163/163
(100 %)
1 diff
(99.4 %id)
AW242853 Kidney .c 1800 to 1942 145 to 3       143/145
(98 %)
0 diff
(100 %id)
AI567176 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1812 to 2109 301 to 1       301/303
(99 %)
4 diff
(98.7 %id)
AI520929 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1814 to 2109 297 to 2       296/297
(99 %)
0 diff
(100 %id)
D80650 brain .c 1815 to 1945 130 to 1   fully sequenced,   130/130
(100 %)
0 diff
(100 %id)
AA947439 pooled germ cell tumors .c 1824 to 1945 176 to 55   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 122/133
(91 %)
3 diff
(97.8 %id)
BF446177 Prostate .c 1874 to 2107 240 to 7       234/240
(97 %)
0 diff
(100 %id)
BF216192 brain, glioblastoma .c 1874 to 1974 1 to 101       101/101
(100 %)
6 diff
(94.1 %id)
AA977035 pooled germ cell tumors .c 1888 to 2109 224 to 1       224/224
(100 %)
1 diff
(99.6 %id)
DB355136 whole embryo, mainly head .c 2688 to 3195 505 to 1   tiling clone,   505/505
(100 %)
9 diff
(98.3 %id)
BM472021 eye, retinoblastoma .d 1 to 898 1 to 905 M227H G229W M230H E231G P232A ... tiling clone,   905/1027
(88 %)
14 diff
(98.7 %id)
AK093975 uterus .e 1 to 1821 2 to 1823 exact tiling clone, available from FLJ,   1823/1823
(100 %)
1 diff
(100.0 %id)
DB248728 uterus .e 1 to 412 2 to 413   capped   412/412
(100 %)
0 diff
(100 %id)
DB350982 uterus .e 1329 to 1821 494 to 1   tiling clone,   494/494
(100 %)
1 diff
(99.8 %id)
BM458026 leiomyosarcoma, uterus .e 1462 to 2332 1 to 879       879/1059
(83 %)
6 diff
(99.5 %id)
BU184446 leiomyosarcoma, uterus .e 1519 to 2332 12 to 835       824/870
(94 %)
23 diff
(97.4 %id)
BI598169 brain, hypothalamus .e 1589 to 2205 1 to 650       650/1093
(59 %)
72 diff
(93.5 %id)
TI_45216026   .e 1592 to 2205 88 to 734       647/1177
(54 %)
70 diff
(94.1 %id)
F07126 brain, total brain .e 1593 to 1931 1 to 338       338/338
(100 %)
1 diff
(99.8 %id)
DB479816.
matches multiple genes
hippocampus .e 1595 to 2108 1 to 515     also hits gene MRPL37 515/515
(100 %)
3 diff
(99.5 %id)
AW410033 muscle, rhabdomyosarcoma .e 1595 to 1980 60 to 445   fully sequenced,   386/445
(86 %)
5 diff
(98.9 %id)
BM688694 eye, optic nerve .e 1621 to 2146 9 to 537       529/537
(98 %)
6 diff
(98.9 %id)
CN404771 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 1627 to 2180 1 to 557       557/557
(100 %)
8 diff
(98.6 %id)
CN404773 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1627 to 2137 100 to 615       516/615
(83 %)
6 diff
(99.1 %id)
W07415 lung .e 1657 to 1911 1 to 251       251/258
(97 %)
14 diff
(94.6 %id)
AI919603 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1660 to 1820 162 to 2       161/162
(99 %)
0 diff
(100 %id)
W21421 lung .e 1663 to 2118 1 to 463       463/463
(100 %)
8 diff
(98.3 %id)
AA126318 uterus .e 1663 to 2089 1 to 430       430/434
(99 %)
7 diff
(98.4 %id)
BM706621 eye, optic nerve .e 1663 to 2279 10 to 627   tiling clone, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 618/627
(98 %)
6 diff
(99.1 %id)
AA326481 brain, cerebellum .e 1678 to 2092 1 to 424       424/425
(99 %)
16 diff
(96.3 %id)
W63545 parathyroid gland, parathyroid tumor .e 1697 to 2299 1 to 595       595/682
(87 %)
18 diff
(97.4 %id)
AI984308 Prostate .e 1698 to 1825 133 to 6       128/133
(96 %)
0 diff
(100 %id)
BF739989 Kidney .e 1698 to 1823 127 to 2       126/127
(99 %)
0 diff
(100 %id)
BM801761 duodenal adenocarcinoma, cell line, small intestine .e 1703 to 2463 15 to 778       764/912
(83 %)
6 diff
(99.4 %id)
AA631781 breast .e 1704 to 1825 124 to 3       122/124
(98 %)
0 diff
(100 %id)
BM452596 lymph, lymphoma, cell line .e 1704 to 2558 1 to 860       860/1069
(80 %)
20 diff
(98.2 %id)
Z43997 brain, total brain .e 1709 to 2047 1 to 338       338/338
(100 %)
2 diff
(99.5 %id)
CD637333   .e 1713 to 2315 1 to 605       605/606
(99 %)
16 diff
(97.4 %id)
AA055725 colon, tumor .e 1716 to 1915 1 to 201       201/236
(85 %)
7 diff
(97.1 %id)
AA101004 Pancreas .e 1716 to 2171 1 to 472       472/472
(100 %)
29 diff
(93.9 %id)
AI400374 Prostate .e 1717 to 1823 110 to 4       107/110
(97 %)
0 diff
(100 %id)
F11575 brain, total brain .e 1726 to 1965 1 to 239       239/239
(100 %)
4 diff
(98.4 %id)
F12330 brain, total brain .e 1727 to 2014 31 to 316       286/316
(90 %)
6 diff
(98.2 %id)
T66077 whole brain .e 1727 to 2086 30 to 388       359/393
(91 %)
7 diff
(98.3 %id)
R61478 whole brain .e 1727 to 2085 30 to 390     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 361/397
(90 %)
8 diff
(98.0 %id)
AA733118 heart .e 1740 to 2176 477 to 44   AAA   434/450
(96 %)
0 diff
(100 %id)
R25702 whole brain .e 1748 to 2092 1 to 356       356/361
(98 %)
16 diff
(95.6 %id)
T30909 brain .e 1768 to 2073 1 to 307       307/307
(100 %)
5 diff
(98.4 %id)
R15810 whole brain .e 1787 to 2155 1 to 377     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 377/381
(98 %)
16 diff
(95.9 %id)
BG176636 lymph, lymphoma, cell line .e 1811 to 2577 1 to 767       767/929
(82 %)
19 diff
(98.0 %id)
CN294993 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1846 to 2338 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
BG925397 cartilage .e 1858 to 2429 86 to 660       575/592
(97 %)
6 diff
(99.0 %id)
CN404765 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 1889 to 2442 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
BM709224 eye, optic nerve .e 1914 to 2350 1 to 437   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 437/437
(100 %)
2 diff
(99.6 %id)
AW410034 muscle, rhabdomyosarcoma .e 1950 to 2535 670 to 82   fully sequenced,   589/670
(87 %)
6 diff
(99.2 %id)
H22046 brain .e 1963 to 2284 1 to 323       323/323
(100 %)
7 diff
(97.9 %id)
BU838215 melanotic melanoma, cell line, skin .e 1963 to 2798 1 to 841       841/847
(99 %)
13 diff
(98.5 %id)
BU166790 melanotic melanoma, cell line, skin .e 1963 to 2804 1 to 846       846/960
(88 %)
25 diff
(97.4 %id)
BQ683969 melanotic melanoma, cell line, skin .e 1963 to 2692 1 to 736       736/1004
(73 %)
32 diff
(96.9 %id)
BQ678556 melanotic melanoma, cell line, skin .e 1963 to 2475 1 to 515       515/1022
(50 %)
3 diff
(99.8 %id)
BF333630 colon_normal .e 1968 to 2513 1 to 546       546/546
(100 %)
4 diff
(99.3 %id)
TI_149300798   .e 2010 to 2911 966 to 74   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 893/981
(91 %)
19 diff
(98.1 %id)
CV807178 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 2061 to 2782 1 to 725       725/725
(100 %)
2 diff
(99.8 %id)
TI_149315691   .e 2078 to 2911 913 to 86   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 828/983
(84 %)
15 diff
(98.5 %id)
TI_57228614   .e 2094 to 2772 127 to 806       680/929
(73 %)
6 diff
(99.4 %id)
BI869397 adenocarcinoma, cell line, Liver .e 2095 to 2772 1 to 679       679/712
(95 %)
6 diff
(99.2 %id)
CN404741 embryonic stem cells, DMSO-treated H9 cellline .e 2117 to 2887 1 to 771       771/771
(100 %)
0 diff
(100 %id)
TI_149295634   .e 2132 to 2911 862 to 94   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 769/918
(83 %)
16 diff
(98.3 %id)
BQ016875 lung, Lung Focal Fibrosis .e 2231 to 2911 699 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 681/681
(100 %)
1 diff
(99.9 %id)
BM976799 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 2231 to 2911 699 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 681/681
(100 %)
0 diff
(100 %id)
CB306476 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 2231 to 2911 699 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 681/681
(100 %)
0 diff
(100 %id)
Z21074   .e 2241 to 2501 1 to 261       261/261
(100 %)
7 diff
(97.4 %id)
TI_154128409   .e 2247 to 2911 748 to 85   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 664/949
(69 %)
4 diff
(99.6 %id)
CA417511 Chondrosarcoma Cell line .e 2247 to 2911 682 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 664/672
(98 %)
4 diff
(99.5 %id)
CA439659 lung, Metastatic Chondrosarcoma .e 2286 to 2911 644 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 626/626
(100 %)
6 diff
(99.1 %id)
AA251744 germinal center B cell .e 2289 to 2597 1 to 308   fully sequenced,   308/308
(100 %)
2 diff
(99.4 %id)
BU732361 eye, optic nerve .e 2320 to 2848 545 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 529/529
(100 %)
2 diff
(99.7 %id)
AW028992 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 2321 to 2588 324 to 56   AAA   269/299
(89 %)
0 diff
(100 %id)
BF374003 stomach_normal .e 2324 to 2733 37 to 448       412/448
(91 %)
6 diff
(98.7 %id)
AA055668 colon, tumor .e 2330 to 2751 423 to 1       423/423
(100 %)
3 diff
(99.3 %id)
BM014861 breast, mammary adenocarcinoma, cell line .e 2342 to 2741 1 to 397   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 397/397
(100 %)
3 diff
(99.3 %id)
TI_59392940   .e 2342 to 2741 47 to 443   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 397/397
(100 %)
3 diff
(99.3 %id)
BQ186998 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 2345 to 2906 15 to 572   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 558/572
(97 %)
6 diff
(99.0 %id)
TI_151732899   .e 2345 to 2906 647 to 90   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 558/957
(58 %)
4 diff
(99.6 %id)
BE047141 squamous cell carcinoma, tongue .e 2350 to 2768 436 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 419/419
(100 %)
6 diff
(98.6 %id)
BU683790 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 2352 to 2911 577 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 559/559
(100 %)
3 diff
(99.5 %id)
AA352536   .e 2360 to 2643 1 to 284       284/284
(100 %)
8 diff
(97.2 %id)
AA706923 liver and spleen .e 2370 to 2911 535 to 1       535/535
(100 %)
11 diff
(98.0 %id)
AA705486 liver and spleen .e 2371 to 2768 398 to 1       398/398
(100 %)
4 diff
(99.0 %id)
AA824368   .e 2382 to 2912 532 to 3       530/532
(99 %)
0 diff
(100 %id)
AA094079   .e 2388 to 2623 1 to 230       230/230
(100 %)
9 diff
(96.1 %id)
N55791   .e 2388 to 2551 1 to 164       164/164
(100 %)
0 diff
(100 %id)
CN404775 embryonic stem cells, DMSO-treated H9 cellline .e 2391 to 2911 9 to 529   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 521/529
(98 %)
6 diff
(98.9 %id)
BM672793 eye, optic nerve .e 2392 to 2768 395 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 377/377
(100 %)
0 diff
(100 %id)
BF448725 fibrotheoma, ovary .e 2406 to 2911 506 to 1       506/506
(100 %)
0 diff
(100 %id)
R71788 breast .e 2417 to 2731 328 to 13       316/328
(96 %)
0 diff
(100 %id)
T48383 fetal spleen, Spleen .e 2420 to 2640 1 to 227   fully sequenced,   227/227
(100 %)
2 diff
(99.2 %id)
AI982551 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 2435 to 2855 421 to 1       421/421
(100 %)
3 diff
(99.3 %id)
AI638213 pooled germ cell tumors .e 2437 to 2768 350 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 332/332
(100 %)
1 diff
(99.7 %id)
AW131610 brain, medulloblastoma .e 2437 to 2908 474 to 3       472/474
(99 %)
0 diff
(100 %id)
BF223593 pooled germ cell tumors .e 2437 to 2768 350 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 332/332
(100 %)
9 diff
(97.3 %id)
BE218831 carcinoid, lung .e 2441 to 2910 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
AI798106 B-cell, chronic lymphotic leukemia .e 2445 to 2912 470 to 3       468/470
(99 %)
0 diff
(100 %id)
AI885326 anaplastic oligodendroglioma, brain .e 2445 to 2912 476 to 9       468/476
(98 %)
0 diff
(100 %id)
CA771827 Pancreas, Purified pancreatic islet .e 2446 to 2911 466 to 1       466/466
(100 %)
2 diff
(99.6 %id)
AI141492 heart .e 2447 to 2911 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
CN265502 embryonic stem cells, cell lines H1, H7, andH9 .e 2448 to 2908 64 to 524       461/524
(87 %)
6 diff
(98.9 %id)
BF060746 pooled .e 2448 to 2913 471 to 6       466/471
(98 %)
0 diff
(100 %id)
AA102468 Pancreas .e 2451 to 2912 475 to 1       475/573
(82 %)
14 diff
(97.6 %id)
AI494154 uterus .e 2457 to 2912 460 to 5       456/460
(99 %)
0 diff
(100 %id)
N80285 lung .e 2458 to 2911 462 to 1       462/462
(100 %)
14 diff
(97.0 %id)
AW872781 squamous cell carcinoma, tongue .e 2469 to 2911 453 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 443/443
(100 %)
0 diff
(100 %id)
CB154553 brain .e 2470 to 2911 1 to 442   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 442/442
(100 %)
0 diff
(100 %id)
BX099675 whole brain .e 2473 to 2912 452 to 14       439/452
(97 %)
0 diff
(100 %id)
AI804100 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2474 to 2911 438 to 1       438/438
(100 %)
1 diff
(99.8 %id)
BE046854 squamous cell carcinoma, tongue .e 2474 to 2912 441 to 3       439/441
(99 %)
0 diff
(100 %id)
BG981768 colon_normal .e 2478 to 2910 22 to 454       433/454
(95 %)
6 diff
(98.7 %id)
AI201621 heart .e 2480 to 2874 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
CN404740 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 2481 to 2911 1 to 431   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 431/431
(100 %)
1 diff
(99.8 %id)
BF594705 Kidney .e 2481 to 2911 431 to 1       431/431
(100 %)
2 diff
(99.6 %id)
AI193080 lung .e 2490 to 2912 424 to 3       422/424
(99 %)
0 diff
(100 %id)
AI674942 Prostate .e 2491 to 2911 419 to 1       419/419
(100 %)
3 diff
(99.3 %id)
AA725125 parathyroid gland, parathyroid tumor .e 2500 to 2912 418 to 6       413/418
(98 %)
0 diff
(100 %id)
AA242968 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2500 to 2893 1 to 393   fully sequenced,   393/393
(100 %)
2 diff
(99.5 %id)
AA877753 colon, colon tumor RER+ .e 2502 to 2768 284 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 267/267
(100 %)
1 diff
(99.7 %id)
AW196802 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .e 2517 to 2912 398 to 3       396/398
(99 %)
0 diff
(100 %id)
H21984 brain .e 2521 to 2817 298 to 1       298/298
(100 %)
2 diff
(99.4 %id)
AI458023 pooled .e 2524 to 2912 409 to 21       389/409
(95 %)
0 diff
(100 %id)
R62446 whole brain .e 2534 to 2912 392 to 9       384/392
(97 %)
0 diff
(100 %id)
AA243726 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2534 to 2912 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AI833155 colon .e 2544 to 2912 371 to 3       369/371
(99 %)
0 diff
(100 %id)
F17623 pectoral muscle (after mastectomy) .e 2544 to 2763 1 to 220       220/220
(100 %)
6 diff
(97.3 %id)
AA716496 heart .e 2545 to 2912 369 to 2       368/369
(99 %)
0 diff
(100 %id)
AI191566   .e 2545 to 2912 373 to 7       367/373
(98 %)
0 diff
(100 %id)
AW468307 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .e 2554 to 2912 360 to 2       359/360
(99 %)
0 diff
(100 %id)
AA922538 pooled germ cell tumors .e 2560 to 2911 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
AI633806 pooled germ cell tumors .e 2560 to 2911 352 to 1       352/352
(100 %)
0 diff
(100 %id)
BE503904 pooled germ cell tumors .e 2560 to 2912 354 to 3       352/354
(99 %)
0 diff
(100 %id)
AI638189 pooled germ cell tumors .e 2562 to 2839 315 to 37   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 279/281
(99 %)
9 diff
(96.8 %id)
AA251842 germinal center B cell .e 2567 to 2911 346 to 1   fully sequenced,   346/346
(100 %)
4 diff
(98.9 %id)
AA991581 breast .e 2567 to 2911 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AW135318   .e 2567 to 2911 362 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 345/345
(100 %)
0 diff
(100 %id)
R61479 whole brain .e 2576 to 2911 358 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 341/342
(99 %)
7 diff
(98.0 %id)
R15809 whole brain .e 2576 to 2848 283 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 273/273
(100 %)
0 diff
(100 %id)
AI219764   .e 2595 to 2911 328 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 317/317
(100 %)
3 diff
(99.1 %id)
T48384 fetal spleen, Spleen .e 2610 to 2911 306 to 1   fully sequenced,   306/306
(100 %)
3 diff
(99.1 %id)
F09228 brain, total brain .e 2615 to 2911 297 to 1       297/297
(100 %)
1 diff
(99.7 %id)
AA002252.
matches multiple genes
liver and spleen .e 2615 to 2974 367 to 1     also hits gene doyspeyby 367/442
(83 %)
9 diff
(98.0 %id)
N92964 lung .e 2623 to 2912 299 to 2       298/299
(99 %)
0 diff
(100 %id)
FN101766 breast carcinoma .e 2624 to 2686 1 to 65       65/66
(98 %)
2 diff
(97.0 %id)
AJ289818   .e 2635 to 2768 1 to 134       134/135
(99 %)
1 diff
(99.3 %id)
T65318 whole brain .e 2643 to 2826 184 to 1       184/184
(100 %)
0 diff
(100 %id)
Z40052 brain, total brain .e 2666 to 2911 246 to 1       246/246
(100 %)
1 diff
(99.6 %id)
AA128177 uterus .e 2666 to 2911 246 to 1       246/246
(100 %)
0 diff
(100 %id)
W72004 heart .e 2667 to 2912 246 to 1       246/284
(86 %)
0 diff
(100 %id)
AA588699 colon, colon tumor .e 2668 to 2839 185 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 172/172
(100 %)
0 diff
(100 %id)
F03413 brain, total brain .e 2685 to 2911 227 to 1       227/227
(100 %)
1 diff
(99.6 %id)
AA242833 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2699 to 2911 213 to 1   fully sequenced,   213/213
(100 %)
0 diff
(100 %id)
BE536244 cervix .e 2699 to 2904 1 to 203       203/203
(100 %)
5 diff
(97.6 %id)
BG099528 adenocarcinoma (mucinous component), colon .e 2703 to 2910 212 to 5       208/242
(85 %)
0 diff
(100 %id)
AI003190   .e 2717 to 2912 203 to 8       196/203
(96 %)
0 diff
(100 %id)
FN175957 breast carcinoma .e 2801 to 2920 1 to 120       120/120
(100 %)
2 diff
(98.4 %id)
AW291808   .e 2905 to 3031 147 to 21   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 127/150
(84 %)
0 diff
(100 %id)
CX752477 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 1 to 663 1 to 663 Q124L tiling clone, Submitted on the opposite strand 724/741
(97 %)
4 diff
(99.5 %id)
DB248093 uterus .g 1 to 520 2 to 521   tiling clone, capped   520/520
(100 %)
0 diff
(100 %id)
BG030881 breast, mammary adenocarcinoma, cell line .g 15 to 690 1 to 672   tiling clone,   672/951
(70 %)
8 diff
(99.2 %id)
BQ440230 melanotic melanoma, skin .g 20 to 703 1 to 693   tiling clone,   693/780
(88 %)
17 diff
(97.9 %id)
EC524572 Prostate .g 428 to 534 1 to 106       108/106
(101 %)
8 diff
(92.5 %id)
BX401490   .g 559 to 1436 969 to 65   tiling clone,   905/969
(93 %)
18 diff
(98.2 %id)
DB350947 uterus .g 1531 to 1732 203 to 1   tiling clone,   203/203
(100 %)
1 diff
(99.6 %id)
W91959 liver and spleen .h 1 to 429 1 to 429   tiling clone, fully sequenced,   429/429
(100 %)
4 diff
(99.1 %id)
BM666446 eye, optic nerve .h 247 to 699 471 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 453/462
(98 %)
1 diff
(99.8 %id)
W91960 liver and spleen .h 368 to 700 335 to 2   tiling clone, fully sequenced,   334/335
(99 %)
0 diff
(100 %id)
BG928867 cartilage .h 497 to 1095 686 to 85   tiling clone,   602/618
(97 %)
0 diff
(100 %id)
CN288789 embryonic stem cells, DMSO-treated H9 cellline .h 587 to 758 1 to 172       172/172
(100 %)
1 diff
(99.5 %id)
AF176918 normal aorta .h 626 to 1652 1028 to 1   tiling clone, Submitted on the opposite strand 1028/1072
(95 %)
3 diff
(99.8 %id)
AL133745 amygdala .h 845 to 1484 1 to 637   tiling clone,   637/637
(100 %)
5 diff
(99.3 %id)
AA308646 colon .h 1431 to 1828 1 to 400       400/400
(100 %)
3 diff
(99.3 %id)
DN991912 brain, whole brain .h 1453 to 2084 8 to 639   tiling clone,   632/639
(98 %)
6 diff
(99.1 %id)
BP418168 small intestine .h 1755 to 2249 496 to 2       495/496
(99 %)
0 diff
(100 %id)
BX505323   .h 1763 to 2428 666 to 1     Submitted on the opposite strand 666/666
(100 %)
2 diff
(99.7 %id)
CN360658 embryonic stem cells, DMSO-treated H9 cellline .h 2040 to 2587 10 to 557   tiling clone,   548/557
(98 %)
6 diff
(99.0 %id)
W78846 liver and spleen .h 2381 to 2868 1 to 489   tiling clone,   489/489
(100 %)
1 diff
(99.8 %id)
CR747974   .h 2432 to 2862 1 to 431       431/431
(100 %)
0 diff
(100 %id)
AA778331 heart .h 2690 to 3230 539 to 1   tiling clone,   539/539
(100 %)
2 diff
(99.7 %id)
BF056423 pooled .h 2875 to 3246 372 to 1       372/372
(100 %)
2 diff
(99.5 %id)
AU158952 thyroid gland .h 3010 to 3555 543 to 1       543/543
(100 %)
11 diff
(98.0 %id)
W80744 liver and spleen .h 3057 to 3242 184 to 1       184/184
(100 %)
4 diff
(97.9 %id)
AI811879 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 3118 to 3556 439 to 1   tiling clone,   439/439
(100 %)
0 diff
(100 %id)
DA317936 hippocampus .i 1 to 551 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AI651242 pooled germ cell tumors .j 1 to 451 459 to 9   tiling clone,   451/459
(98 %)
0 diff
(100 %id)
AW071636 pooled germ cell tumors .j 35 to 459 425 to 1       425/428
(99 %)
4 diff
(99.1 %id)
AW292110   .j 41 to 459 436 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 419/419
(100 %)
0 diff
(100 %id)
AL515451 neuroblastoma, placenta .k 1 to 784 786 to 1 F2X P5L G6X S7X G8A ... tiling clone,   786/857
(91 %)
46 diff
(94.7 %id)
H68962 liver and spleen .l-u 1 to 322 1 to 323   tiling clone, fully sequenced,   323/323
(100 %)
0 diff
(100 %id)
AI248266 liver and spleen .l-u 178 to 603 426 to 1   tiling clone,   426/461
(92 %)
0 diff
(100 %id)
H68931 liver and spleen .l-u 292 to 591 297 to 1   fully sequenced,   297/297
(100 %)
3 diff
(99.0 %id)
DA542588 lung .m 1 to 576 2 to 577 exact tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
DB144326 thymus .n 1 to 523 2 to 525 exact tiling clone, capped   524/524
(100 %)
1 diff
(99.9 %id)
AA195580 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 1 to 454 1 to 457 L24H Y25V E27* tiling clone, fully sequenced,   457/457
(100 %)
6 diff
(98.7 %id)
AA194878 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 254 to 461 235 to 29   tiling clone, fully sequenced, AAA   207/207
(100 %)
1 diff
(99.6 %id)
CD365176 Alveolar Macrophage, lung Gene SSBP3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BM672028 eye, fetal eye Gene SSBP3, variant not shown       AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)    
BM720112 eye, fetal eye Gene SSBP3, variant not shown         Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)    
DB317283 brain Gene SSBP3, variant not shown         Suspected internal deletion, this clone was ignored    
DA522190 brain Gene SSBP3, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB317676 brain Gene SSBP3, variant not shown              
DA530743 brain Gene SSBP3, variant not shown       capped      
AK023883 thyroid gland Gene SSBP3, variant not shown       available from FLJ,      
AW270485 endometrioid ovarian metastasis, ovary Gene SSBP3, variant not shown              
BF942274 medullary carcinoma, thyroid Gene SSBP3, variant not shown              
BF942277 medullary carcinoma, thyroid Gene SSBP3, variant not shown              
BF942354 medullary carcinoma, thyroid Gene SSBP3, variant not shown              
DB381297 placenta Gene SSBP3, variant not shown              
DA834185 placenta Gene SSBP3, variant not shown       capped      
TI_227714404   Gene SSBP3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI